Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raphael Dolin, M.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Mentoring
Available: 07/21/17, Expires: 08/01/21

Field trials of candidate HIV vaccines have shown either no efficacy or only borderline efficacy. Students will review the results of such trials, and examine their experimental design and conduct. Students will have the opportunity to participate as observers in ongoing HIV clinical vaccine trials in the Harvard Clinical Trial Unit. Particular emphasis will be placed on an understanding of ethical issues of such trials and on the principles of rigorous analysis of clinical observations. Laboratory studies of immune responses to vaccination with candidate HIV vaccines will also be available to the scholars. The laboratory studies emphasize characterization of neutralizing antibodies against HIV, as well as cell mediated immune responses to vaccination. Students will have the opportunity to participate in the laboratory procedures, themselves, as well as to analyze results.


Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U19AI096040 (BAROUCH, DAN H.) Jun 13, 2012 - May 31, 2017
    NIH/NIAID
    Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
    Role: Co-Principal Investigator
  2. U19AI078526 (BAROUCH, DAN H.) Aug 15, 2008 - Jul 31, 2014
    NIH/NIAID
    Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine
    Role: Co-Principal Investigator
  3. UM1AI069412 (DOLIN, RAPHAEL) Jan 15, 2007 - Nov 30, 2020
    NIH/NIAID
    Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
    Role: Principal Investigator
  4. U01AI069412 (DOLIN, RAPHAEL) Jan 15, 2007 - Dec 31, 2013
    NIH/NIAID
    Harvard Medical School Vaccine Clinical Trials Unit
    Role: Principal Investigator
  5. U19AI067854 (HAYNES, BARTON F) Jul 14, 2005 - Jun 30, 2013
    NIH/NIAID
    (CHAVI) Center for HIV/AIDS Vaccine Immunology
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Baden LR, Walsh SR, Seaman MS, Cohen YZ, Johnson JA, Licona JH, Filter RD, Kleinjan JA, Gothing JA, Jennings J, Peter L, Nkolola J, Abbink P, Borducchi EN, Kirilova M, Stephenson KE, Pegu P, Eller MA, Trinh HV, Rao M, Ake JA, Sarnecki M, Nijs S, Callewaert K, Schuitemaker H, Hendriks J, Pau MG, Tomaka F, Korber BT, Alter G, Dolin R, Earl PL, Moss B, Michael NL, Robb ML, Barouch DH. First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector. J Infect Dis. 2018 07 13; 218(4):633-644. PMID: 29669026.
    Citations:    Fields:    
  2. Baden LR, Karita E, Mutua G, Bekker LG, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath MJ, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Ann Intern Med. 2016 Mar 01; 164(5):313-22. PMID: 26833336.
    Citations: 9     Fields:    Translation:HumansCells
  3. Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA, Golden KL, Viani KL, Stachler MD, Chen BJ, Pau MG, Weijtens M, Carey BR, Miller CA, Swann EM, Wolff M, Loblein H, Seaman MS, Dolin R, Barouch DH. Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. J Infect Dis. 2015 Feb 15; 211(4):518-28. PMID: 25165165.
    Citations: 18     Fields:    Translation:HumansCellsCTClinical Trials
  4. Baden LR, Walsh SR, Seaman MS, Johnson JA, Tucker RP, Kleinjan JA, Gothing JA, Engelson BA, Carey BR, Oza A, Bajimaya S, Peter L, Bleckwehl C, Abbink P, Pau MG, Weijtens M, Kunchai M, Swann EM, Wolff M, Dolin R, Barouch DH. First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis. 2014 Oct 01; 210(7):1052-61. PMID: 24719474.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  5. Cohen YZ, Dolin R. Novel HIV vaccine strategies: overview and perspective. Ther Adv Vaccines. 2013 Sep; 1(3):99-112. PMID: 24757518.
    Citations: 10     
  6. Dolin R. The quadrivalent approach to influenza vaccination. J Infect Dis. 2013 Aug 15; 208(4):539-40. PMID: 23847061.
    Citations: 1     Fields:    Translation:Humans
  7. Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR. Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis. 2013 Jun 15; 207(12):1888-97. PMID: 23482644.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  8. Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR. Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17; 31(1):114-9. PMID: 23142302.
    Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
  9. Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, Weijtens M, Goudsmit J, Walsh SR, Dolin R, Baden LR. Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):248-56. PMID: 23125443.
    Citations: 37     Fields:    Translation:HumansCells
  10. Baden LR, Walsh SR, Seaman MS, Tucker RP, Krause KH, Patel A, Johnson JA, Kleinjan J, Yanosick KE, Perry J, Zablowsky E, Abbink P, Peter L, Iampietro MJ, Cheung A, Pau MG, Weijtens M, Goudsmit J, Swann E, Wolff M, Loblein H, Dolin R, Barouch DH. First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):240-7. PMID: 23125444.
    Citations: 37     Fields:    Translation:HumansCells
  11. Baden LR, Dolin R. The road to an effective HIV vaccine. N Engl J Med. 2012 Apr 05; 366(14):1343-4. PMID: 22475599.
    Citations: 8     Fields:    Translation:HumansCells
  12. Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. J Infect Dis. 2011 Nov 15; 204(10):1541-9. PMID: 21940420.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  13. Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One. 2011; 6(8):e21225. PMID: 21857901.
    Citations: 66     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  14. Walsh SR, Dolin R. Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines. 2011 Aug; 10(8):1221-40. PMID: 21854314.
    Citations: 22     Fields:    Translation:HumansAnimalsCells
  15. Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18; 29(32):5203-9. PMID: 21619905.
    Citations: 72     Fields:    Translation:HumansAnimalsCells
  16. Dolin R. Resistance to neuraminidase inhibitors. Clin Infect Dis. 2011 Feb 15; 52(4):438-9. PMID: 21248366.
    Citations: 1     Fields:    Translation:HumansCells
  17. Dolin R. Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients. Clin Infect Dis. 2011 Jan 01; 52(1):147-9. PMID: 21148533.
    Citations: 1     Fields:    Translation:HumansCells
  18. Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis. 2010 May 01; 201(9):1361-70. PMID: 20350191.
    Citations: 26     Fields:    Translation:HumansCells
  19. Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R. Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis. 2010 May 01; 201(9):1353-60. PMID: 20350190.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  20. Dolin R. HIV vaccine trial results--an opening for further research. N Engl J Med. 2009 Dec 03; 361(23):2279-80. PMID: 19843556.
    Citations: 11     Fields:    Translation:Humans
  21. Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine. 2009 Mar 04; 27(10):1549-56. PMID: 19168105.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  22. Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL. The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays. Vaccine. 2009 Feb 18; 27(8):1154-65. PMID: 19146908.
    Citations: 11     Fields:    Translation:HumansCells
  23. Dolin R. A new class of anti-HIV therapy and new challenges. N Engl J Med. 2008 Oct 02; 359(14):1509-11. PMID: 18832250.
    Citations: 4     Fields:    Translation:HumansCells
  24. Dolin R. Noroviruses--challenges to control. N Engl J Med. 2007 Sep 13; 357(11):1072-3. PMID: 17855667.
    Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
  25. Dolin R. Influenza--interpandemic as well as pandemic disease. N Engl J Med. 2005 Dec 15; 353(24):2535-7. PMID: 16354889.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  26. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971. J Infect Dis. 2004 Jun 01; 189(11):2142-7, discussion 2139-41. PMID: 15143483.
    Citations: 1     Fields:    Translation:HumansCells
  27. Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, Mulligan M, Goepfert P. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 01; 29(3):254-61. PMID: 11873074.
    Citations: 23     Fields:    Translation:HumansCellsCTClinical Trials
  28. Dolin R. HIV vaccines for prevention of infection and disease in humans. Infect Dis Clin North Am. 2000 Dec; 14(4):1001-16. PMID: 11144638.
    Citations:    Fields:    Translation:HumansCells
  29. McElrath MJ, Corey L, Montefiori D, Wolff M, Schwartz D, Keefer M, Belshe R, Graham BS, Matthews T, Wright P, Gorse G, Dolin R, Berman P, Francis D, Duliege AM, Bolognesi D, Stablein D, Ketter N, Fast P. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 2000 Jun 10; 16(9):907-19. PMID: 10875616.
    Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
  30. Dolin R. Enterovirus 71--emerging infections and emerging questions. N Engl J Med. 1999 Sep 23; 341(13):984-5. PMID: 10498495.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  31. Dolin R. Gaining ground in progressive multifocal leukoencephalopathy. Neurology. 1999 Feb; 52(3):440-1. PMID: 10025768.
    Citations:    Fields:    Translation:Humans
  32. Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, Belshe R, Dolin R, Jackson S, Xu S, Fast P, Walker MC, Stablein D, Excler JL, Tartaglia J, Paoletti E, et al. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis. 1998 May; 177(5):1230-46. PMID: 9593008.
    Citations: 43     Fields:    Translation:HumansCellsCTClinical Trials
  33. Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis. 1998 Feb; 177(2):310-9. PMID: 9466516.
    Citations: 31     Fields:    Translation:HumansCellsCTClinical Trials
  34. Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone L. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antivir Ther. 1997 Dec; 2(4):237-47. PMID: 11327443.
    Citations: 2     Fields:    Translation:Humans
  35. Spino C, Kahn JO, Dolin R, Phair JP. Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15; 15(5):346-55. PMID: 9342254.
    Citations: 2     Fields:    Translation:HumansCells
  36. Krogstad DJ, Pearson RD, Bennett JE, Dolin R, Mandell GL. Dosage for malaria treatment. Lancet. 1996 Nov 09; 348(9037):1311; author reply 1311-2. PMID: 8909393.
    Citations:    Fields:    Translation:Humans
  37. Welles SL, Jackson JB, Yen-Lieberman B, Demeter L, Japour AJ, Smeaton LM, Johnson VA, Kuritzkes DR, D'Aquila RT, Reichelderfer PA, Richman DD, Reichman R, Fischl M, Dolin R, Coombs RW, Kahn JO, McLaren C, Todd J, Kwok S, Crumpacker CS. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis. 1996 Oct; 174(4):696-703. PMID: 8843205.
    Citations: 11     Fields:    Translation:HumansCells
  38. Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 1996 May 20; 12(8):683-93. PMID: 8744579.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  39. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 01; 12(1):38-45. PMID: 8624759.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  40. Gorse GJ, Keefer MC, Belshe RB, Matthews TJ, Forrest BD, Hsieh RH, Koff WC, Hanson CV, Dolin R, Weinhold KJ, Frey SE, Ketter N, Fast PE. A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):330-9. PMID: 8568293.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  41. Dolin RH. Internet medical resources. Ann Intern Med. 1996 Feb 01; 124(3):375. PMID: 8554245.
    Citations:    Fields:    Translation:Humans
  42. Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):340-8. PMID: 8568294.
    Citations: 168     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  43. Demeter LM, Nawaz T, Morse G, Dolin R, Dexter A, Gerondelis P, Reichman RC. Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy. J Infect Dis. 1995 Dec; 172(6):1480-5. PMID: 7594706.
    Citations: 4     Fields:    Translation:HumansCells
  44. Dolin R. Human studies in the development of human immunodeficiency virus vaccines. J Infect Dis. 1995 Nov; 172(5):1175-83. PMID: 7594651.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  45. Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD, et al. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group. Arch Intern Med. 1995 May 08; 155(9):961-74. PMID: 7726705.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  46. Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, et al. Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. J Infect Dis. 1994 Oct; 170(4):782-6. PMID: 7930718.
    Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
  47. Belshe RB, Bolognesi DP, Clements ML, Corey L, Dolin R, Mestecky J, Mulligan M, Stablein D, Wright P. HIV infection in vaccinated volunteers. JAMA. 1994 Aug 10; 272(6):431. PMID: 8040971.
    Citations: 3     Fields:    Translation:Humans
  48. Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA. 1994 Aug 10; 272(6):475-80. PMID: 7913731.
    Citations: 34     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  49. Grasela TH, Walawander CA, Beltangady M, Knupp CA, Martin RR, Dunkle LM, Barbhaiya RH, Pittman KA, Dolin R, Valentine FT, et al. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis. 1994 Jun; 169(6):1250-5. PMID: 8195601.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  50. Dolin RH, Stringer WW. Timing of BAL in suspected PCP. J Gen Intern Med. 1994 Jun; 9(6):356. PMID: 8078003.
    Citations:    Fields:    Translation:Humans
  51. Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L, et al. Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. J Infect Dis. 1993 Dec; 168(6):1387-95. PMID: 8245523.
    Citations: 13     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  52. el-Daher N, Keefer MC, Reichman RC, Dolin R, Roberts NJ. Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines. J Infect Dis. 1993 Aug; 168(2):306-13. PMID: 8335968.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  53. Reichman RC, Tejani N, Lambert JL, Strussenberg J, Bonnez W, Blumberg B, Epstein L, Dolin R. Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI. Antiviral Res. 1993 Apr; 20(4):267-77. PMID: 8097906.
    Citations: 3     Fields:    Translation:HumansCells
  54. Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, et al. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis. 1993 Mar; 167(3):533-7. PMID: 8095059.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
  55. Lambert JS, Seidlin M, Valentine FT, Reichman RC, Dolin R. Didanosine: long-term follow-up of patients in a phase 1 study. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S40-5. PMID: 8093846.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  56. McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF. Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S32-9. PMID: 8425018.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  57. Beltangady M, Knupp CA, Gustafson N, Barbhaiya RH, Dolin R, Seidlin M, Cooley TP, Rozencweig M. Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S26-31. PMID: 8093845.
    Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
  58. Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al. Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 1992 Dec 15; 80(12):2969-76. PMID: 1467512.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  59. Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med. 1992 Oct 15; 117(8):625-33. PMID: 1530193.
    Citations: 28     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  60. Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis. 1992 Aug; 166(2):244-52. PMID: 1353102.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  61. Seidlin M, Lambert JS, Dolin R, Valentine FT. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS. 1992 Aug; 6(8):831-5. PMID: 1418780.
    Citations: 8     Fields:    Translation:Humans
  62. Madore HP, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, Kapikian AZ, Dolin R. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. J Infect Dis. 1992 Aug; 166(2):235-43. PMID: 1321858.
    Citations: 8     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  63. Drusano GL, Yuen GJ, Morse G, Cooley TP, Seidlin M, Lambert JS, Liebman HA, Valentine FT, Dolin R. Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. Antimicrob Agents Chemother. 1992 Jun; 36(6):1280-3. PMID: 1416828.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  64. Drusano GL, Yuen GJ, Lambert JS, Seidlin M, Dolin R, Valentine FT. Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial. Ann Intern Med. 1992 Apr 01; 116(7):562-6. PMID: 1347442.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  65. Pai SM, Shukla UA, Grasela TH, Knupp CA, Dolin R, Valentine FT, McLaren C, Liebman HA, Martin RR, Pittman KA, et al. Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex. J Clin Pharmacol. 1992 Mar; 32(3):242-7. PMID: 1564128.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  66. Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr (1988). 1992; 5(1):60-4. PMID: 1346633.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  67. Kapikian AZ, Vesikari T, Ruuska T, Madore HP, Christy C, Dolin R, Flores J, Green KY, Davidson BL, Gorziglia M, et al. An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. Adv Exp Med Biol. 1992; 327:59-69. PMID: 1295353.
    Citations: 8     Fields:    Translation:Humans
  68. Knupp CA, Shyu WC, Dolin R, Valentine FT, McLaren C, Martin RR, Pittman KA, Barbhaiya RH. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther. 1991 May; 49(5):523-35. PMID: 1903100.
    Citations: 38     Fields:    Translation:HumansCTClinical Trials
  69. Keefer MC, Bonnez W, Roberts NJ, Dolin R, Reichman RC. Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients. J Infect Dis. 1991 Mar; 163(3):448-53. PMID: 1995718.
    Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
  70. Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15; 114(2):119-27. PMID: 1984386.
    Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
  71. Madore HP, Treanor JJ, Buja R, Dolin R. Antigenic relatedness among the Norwalk-like agents by serum antibody rises. J Med Virol. 1990 Oct; 32(2):96-101. PMID: 1704048.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  72. Dolin R, Lambert JS, Morse GD, Reichman RC, Plank CS, Reid J, Knupp C, McLaren C, Pettinelli C. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S540-9; discussion S549-51. PMID: 1974726.
    Citations: 6     Fields:    Translation:HumansCells
  73. Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15; 112(10):727-37. PMID: 1970466.
    Citations: 99     Fields:    Translation:HumansCellsCTClinical Trials
  74. Gordon SM, Oshiro LS, Jarvis WR, Donenfeld D, Ho MS, Taylor F, Greenberg HB, Glass R, Madore HP, Dolin R, et al. Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community. Am J Epidemiol. 1990 Apr; 131(4):702-10. PMID: 2107737.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  75. Dolin R. Current concepts of control measures for influenza. Trans Am Clin Climatol Assoc. 1990; 101:227-33. PMID: 2486444.
    Citations:    Fields:    Translation:HumansPHPublic Health
  76. Treanor JJ, Madore HP, Dolin R. Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis. J Virol Methods. 1988 Dec; 22(2-3):207-14. PMID: 2851600.
    Citations: 5     Fields:    Translation:HumansCells
  77. Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A, Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 1988 Sep; 7(9):645-50. PMID: 2845349.
    Citations: 18     Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
  78. Treanor J, Dolin R, Madore HP. Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells. Proc Natl Acad Sci U S A. 1988 May; 85(10):3613-7. PMID: 2835775.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  79. Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, Sears SD, Dolin R, Maassab HF, Murphy BR. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988 Feb; 62(2):488-95. PMID: 3336068.
    Citations: 56     Fields:    Translation:HumansAnimalsCells
  80. Dolin R. Genital lesions and aseptic meningitis. Hosp Pract (Off Ed). 1987 Oct 30; 22(10A):27-37. PMID: 2822740.
    Citations:    Fields:    Translation:HumansCells
  81. Truman BI, Madore HP, Menegus MA, Nitzkin JL, Dolin R. Snow Mountain agent gastroenteritis from clams. Am J Epidemiol. 1987 Sep; 126(3):516-25. PMID: 3113235.
    Citations: 8     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  82. Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. J Infect Dis. 1987 Aug; 156(2):379-83. PMID: 3598236.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  83. Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, Disney FA, Talpey WB, Green JL, Francis AB, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics. 1987 Aug; 80(2):275-82. PMID: 3302925.
    Citations: 29     Fields:    Translation:HumansCTClinical Trials
  84. Guest C, Spitalny KC, Madore HP, Pray K, Dolin R, Herrmann JE, Blacklow NR. Foodborne Snow Mountain agent gastroenteritis in a school cafeteria. Pediatrics. 1987 Apr; 79(4):559-63. PMID: 3029660.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  85. Dolin R, Treanor JJ, Madore HP. Novel agents of viral enteritis in humans. J Infect Dis. 1987 Mar; 155(3):365-76. PMID: 3027199.
    Citations: 11     Fields:    Translation:HumansCells
  86. Christy C, Madore HP, Treaner JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R. Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis. 1986 Dec; 154(6):1045-7. PMID: 3023497.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  87. Madore HP, Treanor JJ, Pray KA, Dolin R. Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis. J Clin Microbiol. 1986 Sep; 24(3):456-9. PMID: 3020085.
    Citations: 15     Fields:    Translation:HumansCells
  88. Dolin R, Roessner KD, Treanor JJ, Reichman RC, Phillips M, Madore HP. Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis. J Med Virol. 1986 May; 19(1):11-8. PMID: 3009701.
    Citations: 9     Fields:    Translation:HumansCells
  89. Snyder MH, Clements ML, Betts RF, Dolin R, Buckler-White AJ, Tierney EL, Murphy BR. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol. 1986 May; 23(5):852-7. PMID: 3711273.
    Citations: 14     Fields:    Translation:HumansCells
  90. Madore HP, Treanor JJ, Dolin R. Characterization of the Snow Mountain agent of viral gastroenteritis. J Virol. 1986 May; 58(2):487-92. PMID: 3009862.
    Citations: 12     Fields:    Translation:HumansCells
  91. Brondum J, Spitalny KC, Vogt RL, Godlewski K, Madore HP, Dolin R. Snow Mountain agent associated with an outbreak of gastroenteritis in Vermont. J Infect Dis. 1985 Oct; 152(4):834-7. PMID: 4045234.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  92. Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science. 1985 Mar 15; 227(4692):1296-303. PMID: 2983421.
    Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
  93. Whitley RJ, Soong SJ, Alford CA, Hirsch MS, Schooley R, Oxman MN, Connor JD, Betts R, Dolin R, Reichman RC. Design of therapeutic studies in herpes simplex encephalitis. Lancet. 1985 Feb 02; 1(8423):284-5. PMID: 2857352.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  94. Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, Redfield DC, Savoia MC, Richman DD, Tyrrell DL, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984 Sep 07; 252(9):1147-51. PMID: 6088819.
    Citations: 35     Fields:    Translation:HumansCellsCTClinical Trials
  95. Murphy BR, Clements ML, Madore HP, Steinberg J, O'Donnell S, Betts R, Demico D, Reichman RC, Dolin R, Maassab HF. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May; 149(5):816. PMID: 6726007.
    Citations: 15     Fields:    Translation:HumansCells
  96. Skevakis L, Frasch CE, Zahradnik JM, Dolin R. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J Infect Dis. 1984 Mar; 149(3):387-96. PMID: 6425422.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
  97. Madore HP, Reichman RC, Dolin R. Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation. J Clin Microbiol. 1983 Dec; 18(6):1345-50. PMID: 6655040.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  98. Quinnan GV, Schooley R, Dolin R, Ennis FA, Gross P, Gwaltney JM. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis. 1983 Jul-Aug; 5(4):748-57. PMID: 6622889.
    Citations: 21     Fields:    Translation:HumansCells
  99. Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG, Ashikaga T, Dolin R. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis. 1983 Feb; 147(2):336-40. PMID: 6298318.
    Citations: 18     Fields:    Translation:HumansCellsCTClinical Trials
  100. Kapikian AZ, Wyatt RG, Levine MM, Yolken RH, VanKirk DH, Dolin R, Greenberg HB, Chanock RM. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis. 1983 Jan; 147(1):95-106. PMID: 6296243.
    Citations: 32     Fields:    Translation:HumansCells
  101. Cole J, Dolin R, Fahrner K, Gallenson N, Hall J, Harris W. Retinofugal pathways from albino eyes embryonically transplanted to normal and albino axolotls. Brain Res. 1982 Nov; 281(3):346-9. PMID: 7150982.
    Citations:    Fields:    Translation:Animals
  102. Whitley RJ, Soong SJ, Dolin R, Betts R, Linnemann C, Alford CA. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5. PMID: 7110300.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  103. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 02; 307(10):580-4. PMID: 7050702.
    Citations: 71     Fields:    Translation:HumansCellsCTClinical Trials
  104. Dolin R, Reichman RC, Roessner KD, Tralka TS, Schooley RT, Gary W, Morens D. Detection by immune electron microscopy of the Snow Mountain agent of acute viral gastroenteritis. J Infect Dis. 1982 Aug; 146(2):184-9. PMID: 6286787.
    Citations: 35     Fields:    Translation:HumansCells
  105. Reichman RC, Ginsberg M, Barrett-Connor E, Wyborny C, Connor JD, Redfield D, Savoia MC, Richman DD, Oxman MN, Dandliker PS, Badger GJ, Ashikaga T, Dolin R. Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. A preliminary report. Am J Med. 1982 Jul 20; 73(1A):338-41. PMID: 7048921.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  106. Reichman RC, Fisher SE, Dolin R. Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis. Am J Med. 1982 Jul 20; 73(1A):86-90. PMID: 6285740.
    Citations:    Fields:    Translation:HumansCells
  107. Alford CA, Dolin R, Hirsch MS, Karchmer AW, Whitley RJ. Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013. PMID: 6122821.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  108. Blackwelder WC, Dolin R, Mittal KK, McNamara PM, Payne FJ. A population study of herpesvirus infections and HLA antigens. Am J Epidemiol. 1982 Apr; 115(4):569-76. PMID: 6280494.
    Citations: 2     Fields:    Translation:Humans
  109. Girod JC, Reichman RC, Winn WC, Klaucke DN, Vogt RL, Dolin R. Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch Intern Med. 1982 Mar; 142(3):545-7. PMID: 7065789.
    Citations: 7     Fields:    Translation:HumansCells
  110. Schooley RT, Haynes BF, Grouse J, Payling-Wright C, Fauci AS, Dolin R. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. Blood. 1981 Mar; 57(3):510-7. PMID: 6257313.
    Citations: 4     Fields:    Translation:HumansCells
  111. Whitley RJ, Soong SJ, Hirsch MS, Karchmer AW, Dolin R, Galasso G, Dunnick JK, Alford CA. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 05; 304(6):313-8. PMID: 6255332.
    Citations: 46     Fields:    Translation:HumansCells
  112. Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS. Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cell Immunol. 1980 Dec; 56(2):518-25. PMID: 6258810.
    Citations: 8     Fields:    Translation:HumansCells
  113. Morens DM, Bregman DJ, West CM, Greene MH, Mazur MH, Dolin R, Fisher RI. An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med. 1980 Sep; 93(3):414-9. PMID: 6254415.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  114. Reichman RC, Dolin R. Viral pneumonias. Med Clin North Am. 1980 May; 64(3):491-506. PMID: 6248696.
    Citations:    Fields:    Translation:HumansPHPublic Health
  115. Berg RA, Yolken RH, Rennard SI, Dolin R, Murphy BR, Straus SE. New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet. 1980 Apr 19; 1(8173):851-3. PMID: 6103213.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  116. Pons VG, Canter J, Dolin R. Influenza A/USSR/77 (H1N1) on a university campus. Am J Epidemiol. 1980 Jan; 111(1):23-30. PMID: 7352457.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
  117. Mazur MH, Whitley RJ, Dolin R. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5. PMID: 229783.
    Citations: 3     Fields:    Translation:HumansCells
  118. Haynes BF, Schooley RT, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS. Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Nov; 123(5):2095-101. PMID: 226627.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  119. Dolin R. Nathaniel A. Young, 1939--1979. J Infect Dis. 1979 Aug; 140(2):271-2. PMID: 383856.
    Citations:    Fields:    Translation:Humans
  120. Morens DM, Zweighaft RM, Vernon TM, Gary GW, Eslien JJ, Wood BT, Holman RC, Dolin R. A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent. Lancet. 1979 May 05; 1(8123):964-6. PMID: 87627.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  121. Haynes BF, Schooley RT, Grouse JE, Payling-Wright CR, Dolin R, Fauci AS. Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Feb; 122(2):699-702. PMID: 216749.
    Citations: 9     Fields:    Translation:HumansCells
  122. Dolin R. Amantadine and influenza A. Am Fam Physician. 1979 Jan; 19(1):127-30. PMID: 760422.
    Citations: 1     Fields:    Translation:Humans
  123. Pons VG, Reinertsen JL, Steinberg AD, Dolin R. Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus. J Med Virol. 1979; 4(1):15-23. PMID: 231095.
    Citations: 1     Fields:    Translation:HumansCells
  124. Reichman RC, Pons VG, Murphy BR, Caplan EA, Dolin R. Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J Med Virol. 1979; 4(1):1-14. PMID: 231094.
    Citations: 1     Fields:    Translation:HumansCells
  125. Mazur MH, Dolin R. Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978 Nov; 65(5):738-44. PMID: 581329.
    Citations: 22     Fields:    Translation:Humans
  126. Dolin R, Reichman RC, Mazur MH, Whitley RJ. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88. PMID: 210697.
    Citations: 43     Fields:    Translation:HumansCellsPHPublic Health
  127. Dolin R. Norwalk agent-like particles associated with gastroenteritis in human beings. J Am Vet Med Assoc. 1978 Sep 01; 173(5 Pt 2):615-9. PMID: 100481.
    Citations: 4     Fields:    Translation:HumansCells
  128. Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978 Jun; 88(6):729-34. PMID: 352210.
    Citations: 22     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  129. Dolin R, Murphy BR, Caplan EA. Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans. Infect Immun. 1978 Mar; 19(3):867-74. PMID: 640733.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  130. Wise TG, Dolin R, Mazur MH, Top FH, Edelman R, Ennis FA. Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. J Infect Dis. 1977 Dec; 136 Suppl:S507-17. PMID: 342623.
    Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
  131. Wise TG, Dolin R, Mazur MH, Ennis FA. Serologic responses after two sequential doses of influenza A/New Jersey/76 virus vaccine in normal young adults. J Infect Dis. 1977 Dec; 136 Suppl:S496-9. PMID: 606771.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  132. Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA. Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis. 1977 Dec; 136 Suppl:S435-42. PMID: 342618.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  133. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. J Med Assoc State Ala. 1977 Sep; 47(3):37-42, 66. PMID: 903726.
    Citations:    Fields:    Translation:Humans
  134. Reichman RC, Dolin R, Vincent MM, Fauci AS. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man. Proc Soc Exp Biol Med. 1977 Sep; 155(4):571-6. PMID: 197538.
    Citations: 8     Fields:    Translation:HumansCells
  135. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94. PMID: 195208.
    Citations: 106     Fields:    Translation:HumansCellsCTClinical Trials
  136. Chusid MJ, Fauci AS, Dolin R. Effect of virus infection on polymorphonuclear leucocytes. Lancet. 1977 May 21; 1(8021):1110-1. PMID: 68213.
    Citations:    Fields:    Translation:HumansCells
  137. Dolin R, Richman DD, Murphy BR, Fauci AS. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis. 1977 May; 135(5):714-9. PMID: 300761.
    Citations: 14     Fields:    Translation:HumansCells
  138. Coker-Vann M, Dolin R. Effect of adenine arabinoside on Epstein-Barr virus in vitro. J Infect Dis. 1977 Mar; 135(3):447-53. PMID: 191542.
    Citations: 3     Fields:    Translation:Cells
  139. Thornhill TS, Wyatt RG, Kalica AR, Dolin R, Chanock RM, Kapikian AZ. Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis. 1977 Jan; 135(1):20-7. PMID: 401851.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  140. Houff SA, Miller GL, Lovell CR, Wallen WC, Madden DL, Sever JL, Dolin R. The Guillain-Barré Syndrome and swine influenza vaccination. Trans Am Neurol Assoc. 1977; 102:120-3. PMID: 616087.
    Citations:    Fields:    Translation:HumansPHPublic Health
  141. Wright PF, Dolin R, La Montagne JR. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. J Infect Dis. 1976 Dec; 134(6):633-8. PMID: 794423.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  142. Dolin R. Influenza: current concepts. Am Fam Physician. 1976 Sep; 14(3):72-7. PMID: 961563.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  143. Dolin R, Reichman RC, Fauci AS. Lymphocyte populations in acute viral gastroenteritis. Infect Immun. 1976 Aug; 14(2):422-8. PMID: 1085751.
    Citations: 4     Fields:    Translation:HumansCells
  144. Whitley RJ, Ch'ien LT, Dolin R, Galasso GJ, Alford CA. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9. PMID: 177866.
    Citations: 43     Fields:    Translation:HumansCellsCTClinical Trials
  145. Levy AG, Widerlite L, Schwartz CJ, Dolin R, Blacklow NR, Gardner JD, Kimberg DV, Trier JS. Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterology. 1976 Mar; 70(3):321-5. PMID: 765182.
    Citations: 3     Fields:    Translation:HumansAnimals
  146. Bagely DH, Alexander JC, Gill VJ, Dolin R, Ketcham AS. Late Flavobacterium species meningitis after craniofacial exenteration. Arch Intern Med. 1976 Feb; 136(2):229-31. PMID: 1247355.
    Citations: 4     Fields:    Translation:HumansCells
  147. Dolin R, Levy AG, Wyatt RG, Thornhill TS, Gardner JD. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am J Med. 1975 Dec; 59(6):761-8. PMID: 811119.
    Citations: 33     Fields:    Translation:HumansCells
  148. Dolin R, Gill FA, Nahmias AJ. Genital herpes simplex virus type 1 infection--variability in modes of spread. J Am Vener Dis Assoc. 1975 Dec; 2(2):13-6. PMID: 173699.
    Citations:    Fields:    Translation:HumansCells
  149. Dolin R, Baron S. Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man. Proc Soc Exp Biol Med. 1975 Nov; 150(2):337-9. PMID: 1208546.
    Citations: 1     Fields:    Translation:Humans
  150. Dolin R, Smith HA. Antiviral activity of adenine arabinoside and iododeoxyuridine in human fetal intestinal and tracheal organ cultures. J Infect Dis. 1975 Sep; 132(3):287-95. PMID: 169312.
    Citations: 2     Fields:    Translation:HumansCells
  151. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis. 1974 Jun; 129(6):709-14. PMID: 4209723.
    Citations: 81     Fields:    Translation:HumansCellsPHPublic Health
  152. Agus SG, Falchuk ZM, Sessoms CS, Wyatt RG, Dolin R. Increased jejunal IgA synthesis in vitro during acute infectious nonbacterial gastroenteritis. Am J Dig Dis. 1974 Feb; 19(2):127-31. PMID: 4204312.
    Citations: 3     Fields:    Translation:HumansCells
  153. Buscho R, Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Chanock RM. Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology. Am J Epidemiol. 1973 Sep; 98(3):192-8. PMID: 4741840.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  154. Carter BJ, Koczot FJ, Garrison J, Rose JA, Dolin R. Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol. 1973 Jul 18; 244(133):71-3. PMID: 4269132.
    Citations: 16     Fields:    Translation:HumansCells
  155. Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med. 1973 Jul; 79(1):18-25. PMID: 4721173.
    Citations: 34     Fields:    Translation:HumansPHPublic Health
  156. Wyatt RG, Kalica AR, Dolin R. Ultrastructural study of viral replication in human fetal intestinal organ culture. Arch Gesamte Virusforsch. 1973; 40(3):341-9. PMID: 4121665.
    Citations: 2     Fields:    Translation:HumansCells
  157. Dolin R, Rabson AS. Herpesvirus saimiri: enhancement of adenovirus-associated virus. J Natl Cancer Inst. 1973 Jan; 50(1):205-8. PMID: 4632584.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  158. Dolin R, Blacklow NR, Wyatt RG, Sereno MM. Detection and localization of viruses in human fetal intestinal organ cultures by immunofluorescence. Infect Immun. 1972 Dec; 6(6):958-64. PMID: 4344634.
    Citations: 3     Fields:    Translation:HumansCells
  159. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972 Nov; 10(5):1075-81. PMID: 4117963.
    Citations: 183     Fields:    Translation:HumansCellsPHPublic Health
  160. Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, Kasel JA, Hornick R, Chanock RM. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med. 1972 Jun; 140(2):578-83. PMID: 4624851.
    Citations: 45     Fields:    Translation:HumansAnimals
  161. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis. 1971 Mar; 123(3):307-12. PMID: 5111887.
    Citations: 45     Fields:    Translation:HumansCells
  162. Blacklow NR, Dolin R, Hoggan MD. Studies of the enhancement of an adenovirus-associated virus by herpes simplex virus. J Gen Virol. 1971 Jan; 10(1):29-36. PMID: 5542488.
    Citations: 5     Fields:    Translation:Cells
  163. Dolin R, Blacklow NR, Malmgren RA, Chanock RM. Establishment of human fetal intestinal organ cultures for growth of viruses. J Infect Dis. 1970 Sep; 122(3):227-31. PMID: 4317758.
    Citations: 14     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dolin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (538)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.